Genome sequencing of 320 Chinese children with epilepsy: a clinical and molecular study

Autor: nianji zhan, Haisheng Yan, Ying Yang, Lin Wang, Jing Duan, Zhenzhen Yin, Jianbiao Li, Hongdou Xiao, Jing Zhou, Yushan Huang, Tongda Zhang, Fang Chen, Dongfang Zou, Jianxiang Liao, Feiqiu Wen, Jian Guo, Jingyu Ye, Shida Zhu
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Brain
ISSN: 1460-2156
0006-8950
Popis: The aim of this study is to evaluate the diagnostic value of genome sequencing in children with epilepsy, and to provide genome sequencing-based insights into the molecular genetic mechanisms of epilepsy to help establish accurate diagnoses, design appropriate treatments and assist in genetic counselling. We performed genome sequencing on 320 Chinese children with epilepsy, and interpreted single-nucleotide variants and copy number variants of all samples. The complete pedigree and clinical data of the probands were established and followed up. The clinical phenotypes, treatments, prognoses and genotypes of the patients were analysed. Age at seizure onset ranged from 1 day to 17 years, with a median of 4.3 years. Pathogenic/likely pathogenic variants were found in 117 of the 320 children (36.6%), of whom 93 (29.1%) had single-nucleotide variants, 22 (6.9%) had copy number variants and two had both single-nucleotide variants and copy number variants. Single-nucleotide variants were most frequently found in SCN1A (10/95, 10.5%), which is associated with Dravet syndrome, followed by PRRT2 (8/95, 8.4%), which is associated with benign familial infantile epilepsy, and TSC2 (7/95, 7.4%), which is associated with tuberous sclerosis. Among the copy number variants, there were three with a length
Zou et al. perform whole genome sequencing in 320 Chinese children with epilepsy, and investigate single nucleotide variants and copy number variants in all individuals. The results confirm the value of whole genome sequencing as a first-tier diagnostic test for patients with epilepsy.
Databáze: OpenAIRE